• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创伤性脑损伤后促红细胞生成素和辛伐他汀的协同作用。

Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury.

机构信息

Jesse Brown VA Medical Center, University of Illinois, Chicago, USA.

出版信息

Brain Res. 2010 Nov 11;1360:177-92. doi: 10.1016/j.brainres.2010.09.010. Epub 2010 Sep 15.

DOI:10.1016/j.brainres.2010.09.010
PMID:20833152
Abstract

Simvastatin and recombinant human erythropoietin (rhEpo) are implicated as potential therapeutic candidates for traumatic brain injury (TBI). Prominent effects of simvastatin include its anti-inflammatory, neurotrophic and neuroregenerative actions studied in various models of neuronal injury. On the other hand, rhEpo has been shown to promote cell survival mechanisms by producing anti-apoptotic and cell proliferative actions. Beneficial effects of rhEpo and statin monotherapies have been well studied. However, there are no reports showing combined use of rhEpo and statins after TBI. This investigation examined if combined efficacy of cell proliferative ability of rhEpo along with the neuroregenerative ability of simvastatin will render maximum recovery in a controlled cortical impact (CCI) mouse model of TBI. Results showed that compared to baseline TBI, rhEpo was more effective than simvastatin in promoting cell proliferation while simvastatin was more effective than rhEpo in restoring axonal damage following TBI. Combined treatment with simvastatin and rhEpo maximally restored axonal integrity while simultaneously inducing greater proliferation of newly formed cells resulting in better functional recovery after TBI than either alone. This is the first study showing the efficacy of erythropoietin-simvastatin combinational therapeutic approach in achieving greater structural and cognitive recovery after TBI.

摘要

辛伐他汀和重组人红细胞生成素(rhEpo)被认为是创伤性脑损伤(TBI)的潜在治疗候选药物。辛伐他汀的显著作用包括其在各种神经元损伤模型中研究的抗炎、神经营养和神经再生作用。另一方面,rhEpo 通过产生抗细胞凋亡和细胞增殖作用来促进细胞存活机制。rhEpo 和他汀类药物单一疗法的有益作用已经得到了很好的研究。然而,没有报道显示 TBI 后 rhEpo 和他汀类药物联合使用。这项研究检查了 rhEpo 的细胞增殖能力和辛伐他汀的神经再生能力联合使用是否会在 TBI 的控制性皮质撞击(CCI)小鼠模型中实现最大恢复。结果表明,与 TBI 基线相比,rhEpo 在促进细胞增殖方面比辛伐他汀更有效,而辛伐他汀在 TBI 后恢复轴突损伤方面比 rhEpo 更有效。辛伐他汀和 rhEpo 的联合治疗最大限度地恢复了轴突完整性,同时诱导了更多新形成细胞的增殖,从而在 TBI 后实现了更好的功能恢复,优于单独使用任何一种药物。这是第一项研究表明,rhEpo-辛伐他汀联合治疗方法在实现 TBI 后更大的结构和认知恢复方面的疗效。

相似文献

1
Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury.创伤性脑损伤后促红细胞生成素和辛伐他汀的协同作用。
Brain Res. 2010 Nov 11;1360:177-92. doi: 10.1016/j.brainres.2010.09.010. Epub 2010 Sep 15.
2
Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury.他汀类药物可增加齿状回中的神经发生,减少海马CA3区的迟发性神经元死亡,并改善创伤性脑损伤后大鼠的空间学习能力。
J Neurotrauma. 2007 Jul;24(7):1132-46. doi: 10.1089/neu.2007.0288.
3
Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice.促红细胞生成素对减轻小鼠创伤性脑损伤后脑损伤及改善功能结局的作用。
J Neurosurg. 2008 Sep;109(3):510-21. doi: 10.3171/JNS/2008/109/9/0510.
4
Restoration of cognitive deficits after statin feeding in TBI.他汀类药物喂养后对 TBI 认知缺陷的恢复。
Restor Neurol Neurosci. 2011;29(1):23-34. doi: 10.3233/RNN-2011-0573.
5
Role of gender in outcome after traumatic brain injury and therapeutic effect of erythropoietin in mice.性别在小鼠创伤性脑损伤后的预后中的作用及促红细胞生成素的治疗效果
Brain Res. 2007 Dec 14;1185:301-12. doi: 10.1016/j.brainres.2007.09.052. Epub 2007 Oct 31.
6
Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).重组人促红细胞生成素(rhEPO)对大鼠创伤性脑损伤伴发的脑内炎症介质的抑制作用:一种潜在的神经保护机制
Neurosci Lett. 2007 Oct 2;425(3):177-82. doi: 10.1016/j.neulet.2007.08.022. Epub 2007 Aug 19.
7
Anti-edema effects of rhEpo in experimental traumatic brain injury.重组人促红细胞生成素在实验性创伤性脑损伤中的抗水肿作用
Restor Neurol Neurosci. 2015;33(6):927-41. doi: 10.3233/RNN-150577.
8
Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury.辛伐他汀介导的血管内皮生长因子(VEGF)和脑源性神经营养因子(BDNF)上调、磷脂酰肌醇-3激酶(PI3K)/蛋白激酶B(Akt)信号通路激活以及神经发生增加与创伤性脑损伤后的治疗改善相关。
J Neurotrauma. 2008 Feb;25(2):130-9. doi: 10.1089/neu.2007.0369.
9
The potential role of JAK2/STAT3 pathway on the anti-apoptotic effect of recombinant human erythropoietin (rhEPO) after experimental traumatic brain injury of rats.JAK2/STAT3 通路在重组人促红细胞生成素(rhEPO)对大鼠实验性颅脑损伤后抗细胞凋亡作用中的潜在作用。
Cytokine. 2011 Nov;56(2):343-50. doi: 10.1016/j.cyto.2011.07.018. Epub 2011 Aug 16.
10
Recombinant Erythropoietin Induces Oligodendrocyte Progenitor Cell Proliferation After Traumatic Brain Injury and Delayed Hypoxemia.重组促红细胞生成素在创伤性脑损伤和迟发性低氧血症后诱导少突胶质前体细胞增殖。
Neurotherapeutics. 2023 Oct;20(6):1859-1874. doi: 10.1007/s13311-023-01443-8. Epub 2023 Sep 28.

引用本文的文献

1
Traumatic brain injury: Bridging pathophysiological insights and precision treatment strategies.创伤性脑损伤:连接病理生理见解与精准治疗策略
Neural Regen Res. 2026 Mar 1;21(3):887-907. doi: 10.4103/NRR.NRR-D-24-01398. Epub 2025 Mar 25.
2
The protective effects of statins in traumatic brain injury.他汀类药物在创伤性脑损伤中的保护作用。
Pharmacol Rep. 2024 Apr;76(2):235-250. doi: 10.1007/s43440-024-00582-9. Epub 2024 Mar 7.
3
Recombinant Erythropoietin Induces Oligodendrocyte Progenitor Cell Proliferation After Traumatic Brain Injury and Delayed Hypoxemia.
重组促红细胞生成素在创伤性脑损伤和迟发性低氧血症后诱导少突胶质前体细胞增殖。
Neurotherapeutics. 2023 Oct;20(6):1859-1874. doi: 10.1007/s13311-023-01443-8. Epub 2023 Sep 28.
4
The neuroprotective effect of statin in traumatic brain injury: A systematic review.他汀类药物在创伤性脑损伤中的神经保护作用:一项系统综述。
World Neurosurg X. 2023 May 13;19:100211. doi: 10.1016/j.wnsx.2023.100211. eCollection 2023 Jul.
5
Neurological recovery and antioxidant effect of erythropoietin for spinal cord injury: A systematic review and meta-analysis.促红细胞生成素对脊髓损伤的神经恢复及抗氧化作用:一项系统评价和荟萃分析。
Front Neurol. 2022 Jul 19;13:925696. doi: 10.3389/fneur.2022.925696. eCollection 2022.
6
Novel therapies for combating chronic neuropathological sequelae of TBI.治疗创伤性脑损伤慢性神经病理后遗症的新疗法。
Neuropharmacology. 2019 Feb;145(Pt B):160-176. doi: 10.1016/j.neuropharm.2018.06.021. Epub 2018 Jun 20.
7
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.在脑海绵状血管畸形小鼠模型中,法舒地尔与辛伐他汀对RhoA激酶的抑制作用比较
Stroke. 2017 Jan;48(1):187-194. doi: 10.1161/STROKEAHA.116.015013. Epub 2016 Nov 22.
8
The Controlled Cortical Impact Model of Experimental Brain Trauma: Overview, Research Applications, and Protocol.实验性脑创伤的控制性皮质撞击模型:概述、研究应用及方案
Methods Mol Biol. 2016;1462:177-92. doi: 10.1007/978-1-4939-3816-2_11.
9
Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?实验性创伤性脑损伤后神经行为和认知恢复的联合疗法:越多越好吗?
Prog Neurobiol. 2016 Jul;142:45-67. doi: 10.1016/j.pneurobio.2016.05.002. Epub 2016 May 7.
10
Charting a course for erythropoietin in traumatic brain injury.为创伤性脑损伤中的促红细胞生成素规划方向。
J Transl Sci. 2016 Mar;2(2):140-144. doi: 10.15761/jts.1000131. Epub 2016 Mar 26.